Mizuho Securities Cuts Price Target on Pacira Pharma (PCRX); Sights Conservatism
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Pacira Pharma (PCRX) Tops Q1 EPS by 8c; EXPAREL Sales Rose 14%
May 2, 2016 8:57 AM EDTPacira Pharma (NASDAQ: PCRX) reported Q1 EPS of $0.15, $0.08 better than the analyst estimate of $0.07. Revenue for the quarter came in at $65.5 million versus the consensus estimate of $67.11 million.
EXPAREL net product revenues were $63.8 million in the first quarter of 2016, compared to $56.0 million in... More
Trading Radar for 5/2: AIG (AIG), Ferrari (RACE), Loews (L), On Deck Capital (ONDK), Tenet Healthcare (THC) Report
April 29, 2016 3:24 PM EDTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Earnings:
Boardwalk Pipeline Partners (NYSE: BWP) - consensus EPS $0.35
Broadsoft (Nasdaq: BSFT) - consensus EPS $0.26
CEVA, Inc. (Nasdaq: CEVA) - consensus EPS $0.16
CNA Financial (NYSE: CNA) - consensus EPS $0.63
Diamond Offshore Drilling (NYSE: DO) - consensus EPS $0.27
Education Realty Trust (NYSE: EDR) -... More
